Medication options for bipolar disorder: classes and common drugs

Medications used to treat bipolar disorder include several drug classes: mood stabilizers, antipsychotic medications, and antidepressants given with caution. This overview explains which agents are commonly used, when they are prescribed, what evidence and guidelines say, common side effects and monitoring needs, interactions and special prescribing considerations, and how to prepare for a medication discussion with a clinician.

How medication classes are used in bipolar care

Treatment choices depend on the current phase and longer-term goals. Mood stabilizers are the backbone for preventing swings and treating mania and depression. Antipsychotic medications are often used for acute mania and for maintenance in people who respond to them. Antidepressants may be added for depressive episodes but are typically paired with a stabilizer to reduce the chance of switching into mania. Each class has different monitoring requirements and trade-offs.

Common drugs by class and typical uses

Generic name Common brand name(s) Drug class Typical phase(s) of use
Lithium Eskalith, Lithobid Mood stabilizer Acute mania, maintenance
Valproate (valproic acid) Depakote, Depakene Mood stabilizer / anticonvulsant Acute mania, maintenance
Carbamazepine Tegretol, Equetro Mood stabilizer / anticonvulsant Acute mania, maintenance
Lamotrigine Lamictal Mood stabilizer / anticonvulsant Depressive episodes, maintenance
Quetiapine Seroquel Antipsychotic Mania, bipolar depression, maintenance
Olanzapine Zyprexa Antipsychotic Mania, maintenance (often with antidepressant when needed)
Risperidone Risperdal Antipsychotic Mania, maintenance
Aripiprazole Abilify Antipsychotic Mania, maintenance
Lurasidone Latuda Antipsychotic Bipolar depression
Sertraline Zoloft Selective serotonin reuptake inhibitor (SSRI) – antidepressant Adjunct for bipolar depression (with a mood stabilizer)
Bupropion Wellbutrin Antidepressant (norepinephrine and dopamine activity) Adjunct for bipolar depression (with a mood stabilizer)

Evidence and guideline recommendations

Major clinical guidelines generally support lithium, valproate, and certain antipsychotic medications for treating mania. For bipolar depression, some antipsychotic agents and lamotrigine show benefit. Antidepressants are often used only with a mood stabilizer because of mixed evidence and a measurable risk of causing a mood switch. Guidelines emphasize tailoring choices to the episode type, prior response, side effect profiles, and patient priorities.

Common side effects and monitoring requirements

Side effect patterns help guide monitoring. Lithium requires blood level checks and periodic kidney and thyroid tests. Valproate needs liver tests and platelet counts and is avoided in pregnancy because of birth defect risk. Carbamazepine may lower certain blood counts and interacts with many other drugs, so blood tests and drug-level checks are common. Antipsychotic medications can cause weight gain, changes in blood sugar and lipids, and movement symptoms; routine weight and metabolic monitoring are standard. Antidepressant side effects vary by drug class and include sleep or sexual changes.

Drug interactions and common contraindications

Some mood agents affect or are affected by other medicines. Carbamazepine speeds the breakdown of many drugs, reducing their levels. Valproate can increase concentrations of other medications. Lithium levels rise with certain blood pressure medicines and nonsteroidal anti-inflammatory drugs, so regular testing matters. Pregnancy and breastfeeding change which drugs are recommended; valproate is generally avoided in people who can become pregnant. Kidney or liver impairment will affect dosing and choice for several agents.

Special populations and prescribing considerations

Pregnancy, older age, adolescents, and people with medical comorbidities require adapted approaches. Pregnancy planning often leads clinicians to prefer lithium for maintenance when risks and benefits favor it, while avoiding valproate when possible. Older adults may need lower doses and closer metabolic and movement monitoring. Children and teens have specific approvals and evidence; some antipsychotics have pediatric labeling for acute mania. Kidney and liver disease change which agents are safer.

Practical trade-offs and access considerations

Choosing a medication balances symptom control, side effects, needed tests, and access. Drugs that work well may require blood draws or specialist input. Some agents are available as extended-release or injectable forms that can help with adherence. Cost and insurance coverage vary, and generic options often lower out-of-pocket cost. Simpler regimens reduce monitoring but may offer less protection against relapse. These practical factors are part of clinical decision-making.

How to prepare for a medication discussion with a clinician

Bring a concise history of past medications and what worked or caused side effects, a timeline of mood changes, and a list of current medicines and supplements. Ask about the goals for treatment, how soon benefits might appear, which tests are needed and how often, and which side effects to report. Clarify practical matters like lab locations, follow-up timing, and what to do in case of missed doses or intolerable effects.

References and sources for further clinical review

Authoritative guideline sources include national psychiatric practice guidelines and systematic reviews from clinical organizations. Trusted references for clinicians and reviewers include practice recommendations from major psychiatric associations, national health institute guidelines, and systematic reviews in peer-reviewed journals. The medication list here is general and may not include recently approved agents. Individual treatment decisions require clinical assessment.

Which bipolar medications require blood tests?

How do mood stabilizers compare on monitoring?

Which antipsychotic drugs cause weight gain?

Final notes on medication choices

Medication categories for bipolar disorder—mood stabilizers, antipsychotic drugs, and antidepressants used selectively—serve distinct roles in treating mania, depression, and preventing relapse. Choice depends on episode type, prior response, side effect burden, monitoring needs, and personal circumstances. Use this overview to inform questions for a clinician; individual recommendations require clinical assessment and follow-up.

This article provides general information only and is not medical advice, diagnosis, or treatment. Health decisions should be made with qualified medical professionals who understand individual medical history and circumstances.